New mesothelioma drug turns cancer’s own defenses against it
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative This story matters for Science & Discovery readers tracking student. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. StudentNewsletter curates and briefs the science & discovery stories that matter. Our editorial policy →